Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.42 |
| ▸ | LPL | P06858 | 1/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PLAU | P00749 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 2/20 | 0.37 |
| ▸ | PLK1 | P53350 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27652909 | 0.97 | TP53 (0.48) | TP53TAAR1CYP2A6LPLLIPG | |
| Hydrochloric Acid SCHEMBL7177260 | 0.97 | TP53 (0.48) | TP53TAAR1CYP2A6LPLLIPG | |
| Hydrochloric Acid SCHEMBL29234180 | 0.97 | TP53 (0.48) | TP53TAAR1CYP2A6LPLLIPG | |
| Hydrochloric Acid SCHEMBL27875664 | 0.97 | TP53 (0.48) | TP53TAAR1CYP2A6LPLLIPG | |
| SCHEMBL2971552 | 0.94 | — | — | |
| Bromide SCHEMBL28594605 | 0.92 | TP53 (0.48) | TP53TAAR1CYP2A6LPLLIPG | |
| SCHEMBL12205767 | 0.86 | TP53 (0.43) | TP53TAAR1CYP2A6LPLLIPG | |
| SCHEMBL20591151 | 0.82 | TP53 (0.40) | TP53TAAR1CYP2A6LPLLIPG | |
| Hydrochloric Acid SCHEMBL25251831 | 0.78 | TP53 (0.59) | TP53TAAR1CYP2A6LPLLIPG | |
| SCHEMBL36295 | 0.78 | TP53 (0.67) | TP53TAAR1CYP2A6LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7579057-B2 | Resin molding and worked item therefrom | JSR CORPORATION (JP) | 2009-08-25 | — | — | US | disclosed |
| US-20090202791-A1 | ULTRAVIOLET-CURABLE POLYMER COMPOSITION, RESIN MOLDED ARTICLE AND METHOD FOR PRODUCING SAME | JSR CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20080226930-A1 | Reducing water contact angle of surface by ozone treatment | JSR CORPORATION (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20070084369-A1 | Flexographic printing plate and process for production thereof | JSR CORPORATION (JP) | 2007-04-19 | — | — | US | disclosed |
| EP-1468704-B1 | Medical member mainly comprising syndiotactic 1,2-polybutadiene | JSR CORP (JP) | 2007-02-28 | — | — | EP | disclosed |
| EP-1698654-A1 | METHOD FOR ADHERING POLYBUTADIENE FORMED ARTICLE, POLYBUTADIENE COMPOSITE FORMED ARTICLE MANUFACTURED THEREBY, MEDICAL MEMBER, AND INFUSION FLUID SET | JSR Corporation (JP) | 2006-09-06 | — | — | EP | disclosed |
| US-20060068202-A1 | Resin molding and worked item therefrom | ENEOS MATERIALS CORPORATION (JP) | 2006-03-30 | — | — | US | disclosed |
| EP-1607434-A1 | RESIN MOLDING AND WORKED ITEM THEREFROM | JSR Corporation (JP) | 2005-12-21 | — | — | EP | disclosed |
| US-6930146-B1 | 1,2-polybutadiene, thermoplastic elastomer composition and polymer composition | JSR CORPORATION (JP) | 2005-08-16 | — | — | US | disclosed |
| US-20040206362-A1 | Medical member and medical instrument | JSR CORPORATION (JP) | 2004-10-21 | — | — | US | disclosed |
| EP-1468704-A1 | Medical member mainly comprising syndiotactic 1,2-polybutadiene | JSR Corporation (JP) | 2004-10-20 | — | — | EP | disclosed |
| US-20040067380-A1 | Oil-extended 1,2-polybutadiene and method of manufacturing the polybutadiene, and composition and formed product thereof | JSR CORPORATION (JP) | 2004-04-08 | — | — | US | disclosed |
| EP-1306396-A1 | 1,2-POLYBUTADIENE, THERMOPLASTIC ELASTOMER COMPOSITION AND POLYMER COMPOSITION | JSR Corporation (JP) | 2003-05-02 | — | — | EP | disclosed |